Product NDC: | 55390-179 |
Proprietary Name: | Atracurium Besylate |
Non Proprietary Name: | Atracurium Besylate |
Active Ingredient(s): | 10 mg/mL & nbsp; Atracurium Besylate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-179 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074901 |
Marketing Category: | ANDA |
Start Marketing Date: | 20041029 |
Package NDC: | 55390-179-10 |
Package Description: | 10 VIAL in 1 BOX (55390-179-10) > 10 mL in 1 VIAL |
NDC Code | 55390-179-10 |
Proprietary Name | Atracurium Besylate |
Package Description | 10 VIAL in 1 BOX (55390-179-10) > 10 mL in 1 VIAL |
Product NDC | 55390-179 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Atracurium Besylate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20041029 |
Marketing Category Name | ANDA |
Labeler Name | Bedford Laboratories |
Substance Name | ATRACURIUM BESYLATE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |